共 11 条
- [1] Reduced brain norepi-nephrine and dopamine release in treatment refractory depressiveillness,evidence in support of the catecholamine hypothesis ofmood disorders. Lambert G,Johansson M,Agren H,et a. J Arch Gen Psychiarty . 2005
- [2] Mianserin,a 5-HT2a/2c and alpha 2 antago-nist,in the treatment of sexual dysfunction induced by sero-tonin reuptake inhibitors. Aizenberg D. J Clin Neuro-pharmacol . 1997
- [3] Differential effects of milnacipran, fluvoxamine and paroxetine for inhibited and agitated depression[J] . Shigeru Morishita,Seizaburo Arita.  European Psychiatry . 2004 (7)
- [4] 21世纪中国精神医学的思考. 张明园. 上海精神医学 . 2000
- [5] 精神病学[M]. 人民卫生出版社 , 沈渔〓主编, 2001
- [6] Differential effects of milnacipran, fluvoxam-ine and paroxetine for inhibited and agitated depression. Shigeru M, Seizaburo A. European Psychiatry . 2004
- [7] Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex. Zhang W, Perry KW, Wong DT, et al. Neuropsychopharmacology . 2000
- [8] The effects of paroxe-tine and tianeptine on peripheral makers in major depression. Dortea MS,Nela P,Marina S,et al. Progress in Neuro-psychopharmacology&Biologicalpsychiatry . 2002
- [9] Clinical and theoretical im-plication of5-HT2and DA2receptors occupancy of clozapine,ris-peridone,and olanzapine in schizophrenia. Kapur S,Zipurski RB,Remington G. American Journal of Psychiatry . 1999
- [10] A double-blindcomparison of nefazodone,i mipramine,and placebo inmajor depression. Fontaine R,Ontiveros A,Elie R,et al. Clinical Child Psychology and Psychiatry . 1994